RecruitingNCT05925621

Cognitive Neurology Unit Clinical Registry

Cognitive Neurology Unit's Anti-amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease Clinical Registry


Sponsor

Beth Israel Deaconess Medical Center

Enrollment

500 participants

Start Date

Jul 16, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease


Eligibility

Min Age: 50 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This is a clinical registry — a long-term data collection study — for people with mild cognitive impairment (MCI) or early Alzheimer's disease who are being evaluated and followed at a specialized memory clinic. The registry collects detailed clinical information over time to better understand how these conditions progress and to evaluate treatments. **You may be eligible if:** - You have mild cognitive impairment or early (not moderate or advanced) dementia from Alzheimer's disease, confirmed by cognitive testing - You have a positive amyloid PET scan or abnormal spinal fluid results consistent with Alzheimer's disease - You have had a brain MRI in the past 6 months - You have a care partner (family member or friend who can provide support and information) - You are a patient at the appropriate clinic (BI-Lahey amyloid clinic) - You are on a stable medication regimen **You may NOT be eligible if:** - You have had a recent stroke or TIA (mini-stroke) in the past year - You are pregnant - You have an active autoimmune condition or are on immunosuppressant medications - You have a bleeding disorder or are on blood thinners (warfarin, heparin, DOACs, or dual antiplatelet therapy) - Your dementia is caused by something other than Alzheimer's disease - You carry two copies of the ApoE e4 gene (a genetic risk factor for Alzheimer's) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLecanemab

Observational study


Locations(1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05925621


Related Trials